A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache G Jull, P Trott, H Potter, G Zito, K Niere, D Shirley, J Emberson, ... Spine 27 (17), 1835-1843, 2002 | 1082 | 2002 |
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials J Armitage, C Baigent, E Barnes, DJ Betteridge, L Blackwell, M Blazing, ... The Lancet 393 (10170), 407-415, 2019 | 673 | 2019 |
Oxygen saturation and outcomes in preterm infants BOOST II United Kingdom, Australia, and New Zealand Collaborative Groups New England Journal of Medicine 368 (22), 2094-2104, 2013 | 511 | 2013 |
Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators The Lancet 358 (9296), 1855-1863, 2001 | 425 | 2001 |
Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy DV Havlir, IC Marschner, MS Hirsch, AC Collier, P Tebas, RL Bassett, ... New England Journal of Medicine 339 (18), 1261-1268, 1998 | 354 | 1998 |
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in … RJ Simes, IC Marschner, D Hunt, D Colquhoun, D Sullivan, RAH Stewart, ... Circulation 105 (10), 1162-1169, 2002 | 351 | 2002 |
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy IC Marschner, AC Collier, RW Coombs, RT D'Aquila, V DeGruttola, ... Journal of Infectious Diseases 177 (1), 40-47, 1998 | 319 | 1998 |
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy Cholesterol Treatment Trialists'(CTT) Collaboration PloS one 7 (1), e29849, 2012 | 317 | 2012 |
Package ‘glm2’ I Marschner, MW Donoghoe, MMW Donoghoe Journal 3 (2), 12-15, 2018 | 259 | 2018 |
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival CK Lee, L Davies, YL Wu, T Mitsudomi, A Inoue, R Rosell, C Zhou, ... JNCI: Journal of the National Cancer Institute 109 (6), djw279, 2017 | 250 | 2017 |
Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. CF McDonald, CM Blyth, MD Lazarus, IAN Marschner, CE Barter American journal of respiratory and critical care medicine 152 (5), 1616-1619, 1995 | 198 | 1995 |
Long-term risk stratification for survivors of acute coronary syndromes: results from the long-term intervention with pravastatin in ischemic disease (LIPID) study IC Marschner, D Colquhoun, RJ Simes, P Glasziou, P Harris, BB Singh, ... Journal of the American College of Cardiology 38 (1), 56-63, 2001 | 163 | 2001 |
Risk of serious NSAID‐related gastrointestinal events during long‐term exposure: a systematic review D Schaffer, T Florin, C Eagle, I Marschner, G Singh, M Grobler, C Fenn, ... Medical journal of Australia 185 (9), 501-506, 2006 | 149 | 2006 |
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials C Reith, C Baigent, L Blackwell, J Emberson, E Spata, K Davies, H Halls, ... The Lancet 400 (10355), 832-845, 2022 | 120 | 2022 |
Biosimilarity and interchangeability: principles and evidence: a systematic review RA McKinnon, M Cook, W Liauw, M Marabani, IC Marschner, NH Packer, ... BioDrugs 32, 27-52, 2018 | 116 | 2018 |
Defining the most appropriate primary end point in phase 2 trials of immune checkpoint inhibitors for advanced solid cancers: a systematic review and meta-analysis G Ritchie, H Gasper, J Man, S Lord, I Marschner, M Friedlander, CK Lee JAMA oncology 4 (4), 522-528, 2018 | 107 | 2018 |
Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia TA Ruff, DM Gertig, BF Otto, ID Gust, A Sutanto, TI Soewarso, N Kandun, ... Journal of Infectious Diseases 171 (2), 290-296, 1995 | 105 | 1995 |
A method for estimating the age-specific relative risk of HIV infection from AIDS incidence data NG Becker, IC Marschner Biometrika 80 (1), 165-178, 1993 | 94 | 1993 |
A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer BA Adelstein, TA Dobbins, CA Harris, IC Marschner, RL Ward European journal of cancer 47 (9), 1343-1354, 2011 | 91 | 2011 |
Relative risk regression: reliable and flexible methods for log-binomial models IC Marschner, AC Gillett Biostatistics 13 (1), 179-192, 2012 | 81 | 2012 |